Applicants who have not been fully vaccinated against COVID-19 may experience delays in the progress of their immigration applications. According to the policy requirements of the U.S. Centers for Disease Control and Prevention (CDC): Effective October 1, 2021, applicants must submit proof of full vaccination to the physician prior to the medical examination.
At the same time, the websites of the U.S. Embassy and Consulates in China have previously updated their requirements for COVID-19 vaccination: all immigration applicants requiring a medical examination must complete their COVID-19 vaccination. Unlike other required vaccines, applicants must complete the full series of COVID-19 vaccinations to be considered as having completed the medical examination requirements. The new requirements have been in effect since October 1, 2021.
Meanwhile, U.S. Citizenship and Immigration Services (USCIS) has also adjusted its interview medical examination requirements in accordance with the policies of the U.S. Centers for Disease Control and Prevention (CDC). USCIS announced that, effective October 1, 2021, applicants undergoing an immigration medical examination must be fully vaccinated against COVID-19 to proceed with the examination, although exemptions may be requested for age, health, religious reasons, or in cases of severe vaccine supply shortages.
In addition, the Guangzhou International Travel Healthcare Center, one of the U.S.-designated immigration medical examination hospitals, has reminded U.S. immigration applicants on its WeChat official account: you must complete your vaccinations before the medical examination and bring your original vaccination records and other relevant documents.
Currently, two vaccines from China have been approved by the WHO: Sinopharm and Sinovac (Beijing). Worldway Group once again reminds all investors to complete their vaccinations as soon as possible to ensure a smooth immigration medical examination and to attend their immigration interview as scheduled.
As is well known, the United States, as a traditional major immigration destination, is an excellent choice for investors planning their status. Among these, the EB-5 investment immigration program is favored by investors for its low threshold, minimal requirements, and the benefit of the entire family obtaining a Green Card through a single application. Currently, the reauthorization of the EB-5 Regional Center Program has achieved a phased victory and will continue in a brand-new form until September 30, 2027, providing a relatively long period of policy stability for the EB-5 industry and investors. The act grants a 60-day window for the new EB-5 Regional Center Program, and government agencies such as USCIS will issue relevant implementation policies to put the new act into effect. Worldway Group will continue to maintain close contact with all parties and actively monitor the latest developments.
For those immigrating to the United States, in addition to the EB-5 investment immigration route, investors with plans for a quick move to the U.S. can also immigrate through the EB-1A Extraordinary Ability Immigrant program. The EB-1A program does not require employer sponsorship or a labor certification; it features a short application cycle, fast approval, no visa backlog, and approval can be obtained in 6-8 months. The entire family can obtain a permanent Green Card in one step, and the Green Card is marked E-11, making it convenient for working and living in the United States.
Some materials in this article are sourced from the internet, and the copyright belongs to the original author. If there are any copyright issues, please contact us for removal.
Investment involves risks; the above information is for reference only.